CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Anxo Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Anxo Pharmaceutical Co Ltd
8F-3, No.206, Section 2
Nanking East Road, Jhongshan District
Phone: +886 225042121p:+886 225042121 TAIPEI, 104  Taiwan Ticker: 66776677
Business Summary
Anxo Pharmaceutical Co., Ltd is a Taiwan-based company engaged in the development and application of special pharmaceutical technology platforms and the development, manufacture and sale of special generic drugs. The Company is involved in the research and development of niche-type technology platforms and products with high-tech thresholds and high barriers to entry, as well as the provision of contract development and manufacturing organization (CDMO) services for pharmaceutical companies at home and abroad. The Company’s main operating revenues are from the sale of products, technical services, as well as original equipment manufacturer (OEM) services.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8071 Medical laboratories
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JerryWang 1/1/2024 8/25/2014
Chief Executive Officer, General Manager, Director LinquanYan 1/1/2021 1/1/2013
Head of Finance & Accounting ZhixianChen 10/1/2015 10/1/2015
8 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 55,663,500 (As of 7/11/2023)
Stock Exchange: TPO
Fax Number: +886 225084245


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024